MYELOID
Clinical trials for MYELOID explained in plain language.
Never miss a new study
Get alerted when new MYELOID trials appear
Sign up with your email to follow new studies for MYELOID, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug MP0533 takes aim at Hard-to-Treat leukemia
Disease control OngoingThis early-stage trial tests a new drug called MP0533 in adults with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) that has come back or not responded to treatment. The drug is designed to help the body's immune cells find and attack cancer cells. The study will …
Matched conditions: MYELOID
Phase: PHASE1, PHASE2 • Sponsor: Molecular Partners AG • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Immune cell booster for leukemia patients pulled before start
Disease control TerminatedThis study aimed to see if giving special immune cells (γδ T cells) after a stem cell transplant could help prevent leukemia from coming back in high-risk patients. It was planned for adults aged 18-65 with acute myeloid leukemia. However, the study was withdrawn before any parti…
Matched conditions: MYELOID
Phase: EARLY_PHASE1 • Sponsor: Guangzhou Bio-gene Technology Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC